Last reviewed · How we verify
1 dose MMR
1 dose MMR is a Biologic drug developed by Shanghai Municipal Center for Disease Control and Prevention. It is currently FDA-approved.
One dose of MMR is not mentioned in the provided facts. However, based on the information, MMR-deficient localized colon cancer is being studied in a clinical trial (NCT05662527) to evaluate the efficacy of immunotherapy.
At a glance
| Generic name | 1 dose MMR |
|---|---|
| Sponsor | Shanghai Municipal Center for Disease Control and Prevention |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors (PHASE1, PHASE2)
- A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors. (PHASE1, PHASE2)
- AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors (PHASE1)
- Asciminib Treatment Optimization in ≥ 3rd Line CML-CP (PHASE3)
- Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification (PHASE2, PHASE3)
- Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
- Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) (PHASE3)
- A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 1 dose MMR CI brief — competitive landscape report
- 1 dose MMR updates RSS · CI watch RSS
- Shanghai Municipal Center for Disease Control and Prevention portfolio CI
Frequently asked questions about 1 dose MMR
What is 1 dose MMR?
Who makes 1 dose MMR?
What development phase is 1 dose MMR in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing